These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 28422710

  • 1. The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.
    Liu A, Han A, Zhu H, Ma L, Huang Y, Li M, Jin F, Yang Q, Yu J.
    Oncotarget; 2017 May 16; 8(20):33736-33744. PubMed ID: 28422710
    [Abstract] [Full Text] [Related]

  • 2. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H, Wang R, Zhao F, Zhu K, Jiang S, Zhao W, Feng R.
    Acta Radiol; 2011 Jul 01; 52(6):646-50. PubMed ID: 21508201
    [Abstract] [Full Text] [Related]

  • 3. Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.
    Oncologist; 2011 Jul 01; 16(3):319-26. PubMed ID: 21339258
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE, Karamustafaoğlu YA, Balta C, Süt N, Sarikaya İ, Sarikaya A.
    Nucl Med Commun; 2018 Nov 01; 39(11):995-1004. PubMed ID: 30188416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer.
    Ishimura M, Norikane T, Mitamura K, Yamamoto Y, Arai-Okuda H, Murota M, Ibuki E, Kanaji N, Nishiyama Y.
    Nucl Med Commun; 2022 Mar 01; 43(3):304-309. PubMed ID: 34908022
    [Abstract] [Full Text] [Related]

  • 17. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
    Li C, Tian Y, Shen Y, Wen B, He Y.
    AJR Am J Roentgenol; 2021 Dec 01; 217(6):1433-1443. PubMed ID: 33978465
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 01; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 19. Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs.
    Yoshida T, Tanaka H, Kuroda H, Shimizu J, Horio Y, Sakao Y, Inaba Y, Iwata H, Hida T, Yatabe Y.
    Lung Cancer; 2016 Oct 01; 100():14-19. PubMed ID: 27597275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.